to study the effect of vasadi kwath in vatrakta (gout)
Phase 3
- Conditions
- Health Condition 1: M200- Deformity of finger(s)Health Condition 2: M109- Gout, unspecified
- Registration Number
- CTRI/2023/12/060586
- Lead Sponsor
- DR GHULE SHUBHAM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
SR URIC ACID >7MG/DL FOR MEN
SR URIC ACID >6MG/DL FOR WOMEN
CHRONIC CASES OF GOUT
Exclusion Criteria
IMMUNOCOMPROMISED PATIENTS OR PATIENTS ON IMMUNOSUPPRESSIVE DRUGS
PATIENTS SUFFERING FROM LIFE THREATENING DISEASE
PREGNANT WOMEN AND LACTATING MOTHER
PATIENTS WITH CHRONIC KIDNEY DISEASE AND END STAGE RENAL DISEASE AND REQUIRING DIALYSIS
PATIENTS TAKING DIURETICS ASPIRIN ETHAMBUTOL PYRIZINAMIDE CYCLOSPORINE CYTOTOXIC DRUGS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SR URIC ACID LEVEL <br/ ><br>TO BE DONE BEFORE AND AFTER THE TRIALTimepoint: baseline and after 4 weeks
- Secondary Outcome Measures
Name Time Method SR URIC ACID LEVELSTimepoint: BASELINE & EVERY 1 MONTH